rs149127230

Variant summary

Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BA1

This summary comes from the ClinGen Evidence Repository: The c.2104G>A (p.GLu702Lys) variant has an allele frequency of 0.001714 (0.2%, 71/41,414 alleles) in the African subpopulation of the gnomAD cohort (BA1). Therefore, this variant meets criteria to be classified as benign. ACMG/AMP criteria applied, as specified by the CDH1 Variant Curation Expert Panel (Variant Interpretation Guidelines Version 3.1): BA1. LINK:https://erepo.genome.network/evrepo/ui/classification/CA288054/MONDO:0007648/007

Frequency

Genomes: 𝑓 0.00052 ( 1 hom., cov: 32)
Exomes 𝑓: 0.000082 ( 0 hom. )

Consequence

CDH1
NM_004360.5 missense

Scores

1
17

Clinical Significance

Benign reviewed by expert panel U:3B:14

Conservation

PhyloP100: 1.31

Publications

19 publications found
Variant links:
Genes affected
CDH1 (HGNC:1748): (cadherin 1) This gene encodes a classical cadherin of the cadherin superfamily. Alternative splicing results in multiple transcript variants, at least one of which encodes a preproprotein that is proteolytically processed to generate the mature glycoprotein. This calcium-dependent cell-cell adhesion protein is comprised of five extracellular cadherin repeats, a transmembrane region and a highly conserved cytoplasmic tail. Mutations in this gene are correlated with gastric, breast, colorectal, thyroid and ovarian cancer. Loss of function of this gene is thought to contribute to cancer progression by increasing proliferation, invasion, and/or metastasis. The ectodomain of this protein mediates bacterial adhesion to mammalian cells and the cytoplasmic domain is required for internalization. This gene is present in a gene cluster with other members of the cadherin family on chromosome 16. [provided by RefSeq, Nov 2015]
CDH1 Gene-Disease associations (from GenCC):
  • blepharocheilodontic syndrome 1
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P, Illumina
  • CDH1-related diffuse gastric and lobular breast cancer syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), G2P
  • hereditary breast carcinoma
    Inheritance: AD Classification: DEFINITIVE Submitted by: Ambry Genetics
  • hereditary diffuse gastric adenocarcinoma
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics
  • cleft soft palate
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
  • orofacial cleft 3
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
  • blepharocheilodontic syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • familial ovarian cancer
    Inheritance: Unknown Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -8 ACMG points.

BA1
For more information check the summary or visit ClinGen Evidence Repository.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_004360.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CDH1
NM_004360.5
MANE Select
c.2104G>Ap.Glu702Lys
missense
Exon 13 of 16NP_004351.1A0A0U2ZQU7
CDH1
NM_001317184.2
c.1921G>Ap.Glu641Lys
missense
Exon 12 of 15NP_001304113.1P12830-2
CDH1
NM_001317185.2
c.556G>Ap.Glu186Lys
missense
Exon 13 of 16NP_001304114.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CDH1
ENST00000261769.10
TSL:1 MANE Select
c.2104G>Ap.Glu702Lys
missense
Exon 13 of 16ENSP00000261769.4P12830-1
CDH1
ENST00000422392.6
TSL:1
c.1921G>Ap.Glu641Lys
missense
Exon 12 of 15ENSP00000414946.2P12830-2
CDH1
ENST00000562836.5
TSL:1
n.2175G>A
non_coding_transcript_exon
Exon 12 of 15

Frequencies

GnomAD3 genomes
AF:
0.000519
AC:
79
AN:
152142
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00171
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000655
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000735
Gnomad OTH
AF:
0.000478
GnomAD2 exomes
AF:
0.000167
AC:
42
AN:
251084
AF XY:
0.000125
show subpopulations
Gnomad AFR exome
AF:
0.00148
Gnomad AMR exome
AF:
0.0000867
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0000544
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000880
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000821
AC:
120
AN:
1461672
Hom.:
0
Cov.:
34
AF XY:
0.0000811
AC XY:
59
AN XY:
727120
show subpopulations
African (AFR)
AF:
0.00161
AC:
54
AN:
33478
American (AMR)
AF:
0.0000671
AC:
3
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.0000383
AC:
1
AN:
26136
East Asian (EAS)
AF:
0.0000504
AC:
2
AN:
39700
South Asian (SAS)
AF:
0.000162
AC:
14
AN:
86254
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53236
Middle Eastern (MID)
AF:
0.000521
AC:
3
AN:
5754
European-Non Finnish (NFE)
AF:
0.0000342
AC:
38
AN:
1112000
Other (OTH)
AF:
0.0000828
AC:
5
AN:
60392
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.489
Heterozygous variant carriers
0
7
13
20
26
33
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000519
AC:
79
AN:
152142
Hom.:
1
Cov.:
32
AF XY:
0.000444
AC XY:
33
AN XY:
74308
show subpopulations
African (AFR)
AF:
0.00171
AC:
71
AN:
41414
American (AMR)
AF:
0.0000655
AC:
1
AN:
15274
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5198
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4826
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10606
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.0000735
AC:
5
AN:
68032
Other (OTH)
AF:
0.000478
AC:
1
AN:
2094
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
4
9
13
18
22
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000311
Hom.:
0
Bravo
AF:
0.000529
ESP6500AA
AF:
0.00182
AC:
8
ESP6500EA
AF:
0.000116
AC:
1
ExAC
AF:
0.000214
AC:
26
EpiCase
AF:
0.0000545
EpiControl
AF:
0.000119

ClinVar

ClinVar submissions
Significance:Benign
Revision:reviewed by expert panel
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
2
3
Hereditary diffuse gastric adenocarcinoma (5)
-
-
4
not provided (4)
-
-
3
Hereditary cancer-predisposing syndrome (3)
-
-
2
not specified (2)
-
-
1
CDH1-related diffuse gastric and lobular breast cancer syndrome (1)
-
1
-
Endometrial carcinoma (1)
-
-
1
Familial cancer of breast;C1140680:Ovarian cancer (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.11
BayesDel_addAF
Benign
-0.49
T
BayesDel_noAF
Benign
-0.49
CADD
Benign
12
DANN
Benign
0.60
DEOGEN2
Benign
0.31
T
Eigen
Benign
-0.91
Eigen_PC
Benign
-0.91
FATHMM_MKL
Benign
0.14
N
LIST_S2
Benign
0.56
T
M_CAP
Benign
0.018
T
MetaRNN
Benign
0.016
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Uncertain
2.5
M
PhyloP100
1.3
PrimateAI
Benign
0.33
T
PROVEAN
Benign
-0.17
N
REVEL
Benign
0.060
Sift
Benign
0.52
T
Sift4G
Benign
0.41
T
Polyphen
0.014
B
Vest4
0.24
MVP
0.69
MPC
0.31
ClinPred
0.014
T
GERP RS
1.5
Varity_R
0.074
gMVP
0.53
Mutation Taster
=84/16
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs149127230; hg19: chr16-68857469; COSMIC: COSV55744367; COSMIC: COSV55744367; API